What is the treatment for Raynaud's (Raynaud's phenomenon) when toes become numb due to digital ischemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The most effective treatment for Raynaud's phenomenon when toes go numb is to keep extremities warm and use calcium channel blockers like nifedipine (10-20 mg three times daily) as first-line treatment. To manage Raynaud's phenomenon, it is essential to avoid triggers such as cold temperatures, stress, and smoking 1. Wearing proper clothing, including warm socks, insulated footwear, and using hand/foot warmers, can help prevent attacks 1. When an attack occurs, warming the feet gradually by soaking them in warm water or moving to a warmer environment can help alleviate symptoms.

For medication options, calcium channel blockers like nifedipine are the first-line treatment, as they help dilate blood vessels and improve blood flow to the extremities 1. Other medications, such as topical nitroglycerin, sildenafil, or losartan, may also be considered, but their use should be guided by a healthcare provider 1. In severe cases, more specialized treatments like intravenous prostacyclins may be necessary 1. It is crucial to consult a healthcare provider if symptoms worsen, develop ulcers, or do not respond to treatment, as this could indicate a more serious underlying condition 1.

Some key points to consider in the management of Raynaud's phenomenon include:

  • Avoiding triggers and keeping extremities warm
  • Using calcium channel blockers as first-line treatment
  • Considering other medications, such as topical nitroglycerin or sildenafil, under the guidance of a healthcare provider
  • Seeking medical attention if symptoms worsen or do not respond to treatment.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Treatment Options for Raynaud's Phenomenon

When toes go numb due to Raynaud's phenomenon, treatment options are available to manage the condition. The following are some of the treatment approaches:

  • Non-pharmacological treatment, including avoiding cold and smoking cessation 2
  • Calcium channel antagonists, such as nifedipine, which can reduce the frequency and severity of vasospastic attacks 3, 2, 4
  • Other pharmacological treatments, including:
    • Prostanoids
    • Bosentan, which can reduce the number of new digital ulcers in scleroderma patients 2
    • Sildenafil
    • Antiaggregants/anticoagulants
    • Antibiotics
    • Analgesics 3
    • Angiotensin II inhibitors
    • Selective serotonin reuptake inhibitors
    • Phosphodiesterase-5 inhibitors
    • Nitrates (topical or oral) 2

Individualized Treatment Approach

It is essential to note that the treatment of Raynaud's phenomenon should be individualized, especially when the condition is severe and accompanied by digital ulcers or tissue necrosis 3. The therapeutic regime may involve combinations of different drugs, and the response to treatment can vary and is difficult to predict 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Treatment of Raynaud's phenomenon].

Revista clinica espanola, 2009

Research

Raynaud's phenomenon: pathogenesis and management.

Journal of the American Academy of Dermatology, 2008

Research

Treatment of Raynaud's phenomenon.

Autoimmunity reviews, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.